Neurological soft signs and cognition among inpatients with schizophrenia

References

• Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: The calgary depression scale. The British Journal of Psychiatry, 163(S22), 39–44. https://doi.org/10.1192/S0007125000292581
   Web of Science ®Google Scholar
• Andreasen, N. C., Pressler, M., Nopoulos, P., Miller, D., & Ho, B.-C. (2010). Antipsychotic dose equivalents and dose-years: A standardized method for comparing exposure to different drugs. Biological Psychiatry, 67(3), 255–262. https://doi.org/10.1016/j.biopsych.2009.08.040
   PubMed Web of Science ®Google Scholar
• Aubin, G., Stip, E., Gélinas, I., Rainville, C., & Chapparo, C. (2009). Daily activities, cognition and community functioning in persons with schizophrenia. Schizophrenia Research, 107(2–3), 313–318. https://doi.org/10.1016/j.schres.2008.08.002
   PubMed Web of Science ®Google Scholar
• Bachmann, S., Degen, C., Geider, F. J., & Schröder, J. (2014). Neurological soft signs in the clinical course of schizophrenia: Results of a meta-analysis. Frontiers in Psychiatry, 5, 185. https://doi.org/10.3389/fpsyt.2014.00185
   PubMed Web of Science ®Google Scholar
• Bachmann, S., & Schröder, J. (2018). Neurological soft signs in schizophrenia: An update on the state-versus trait-perspective. Frontiers in Psychiatry, 8, 272. https://doi.org/10.3389/fpsyt.2017.00272
   PubMed Web of Science ®Google Scholar
• Bansal, P. D., & Gupta, N. (2021). Neurological soft signs in schizophrenia: A cross-sectional study. International Journal of Applied and Basic Medical Research, 11(1), 36. https://doi.org/10.4103/ijabmr.IJABMR_96_20
   PubMedGoogle Scholar
• Birchwood, M., Smith, J., Drury, V., Healy, J., Macmillan, F., & Slade, M. (1994). A self-report insight scale for psychosis: Reliability, validity and sensitivity to change. Acta Psychiatrica Scandinavica, 89(1), 62–67. https://doi.org/10.1111/j.1600-0447.1994.tb01487.x
   PubMed Web of Science ®Google Scholar
• Bottmer, C., Bachmann, S., Pantel, J., Essig, M., Amann, M., Schad, L. R., Magnotta, V., & Schröder, J. (2005). Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Research: Neuroimaging, 140(3), 239–250. https://doi.org/10.1016/j.pscychresns.2005.02.011
   Web of Science ®Google Scholar
• Buchanan, R. W., & Heinrichs, D. W. (1989). The neurological evaluation scale (NES): A structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research, 27(3), 335–350. https://doi.org/10.1016/0165-1781(89)90148-0
   PubMed Web of Science ®Google Scholar
• Carter, C. S., & Barch, D. M. (2007). Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: The CNTRICS initiative. Schizophrenia Bulletin, 33(5), 1131–1137. https://doi.org/10.1093/schbul/sbm081
   PubMed Web of Science ®Google Scholar
• Chan, R. C., Cui, H.-r., Chu, M.-y., Zhang, T.-h., Wang, Y., Wang, Y., Li, Z., Lui, S. S., Wang, J.-j., & Cheung, E. F. (2018). Neurological soft signs precede the onset of schizophrenia: A study of individuals with schizotypy, ultra-high-risk individuals, and first-onset schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 268(1), 49–56. https://doi.org/10.1007/s00406-017-0828-4
   PubMed Web of Science ®Google Scholar
• Chan, R. C., Geng, F.-l., Lui, S. S., Wang, Y., Ho, K. K., Hung, K. S., Gur, R. E., Gur, R. C., & Cheung, E. F. (2015). Course of neurological soft signs in first-episode schizophrenia: Relationship with negative symptoms and cognitive performances. Scientific Reports, 5(1), 1–11. https://doi.org/10.9734/JSRR/2015/14076
   Google Scholar
• Chan, R. C., Xu, T., Heinrichs, R. W., Yu, Y., & Wang, Y. (2010). Neurological soft signs in schizophrenia: A meta-analysis. Schizophrenia Bulletin, 36(6), 1089–1104. https://doi.org/10.1093/schbul/sbp011
   PubMed Web of Science ®Google Scholar
• Cuesta, M. J., Moreno-Izco, L., Ribeiro, M., López-Ilundain, J. M., Lecumberri, P., Cabada, T., Lorente-Omeñaca, R., Sánchez-Torres, A. M., Gómez, M. S., & Peralta, V. (2018). Motor abnormalities and cognitive impairment in first-episode psychosis patients, their unaffected siblings and healthy controls. Schizophrenia Research, 200, 50–55. https://doi.org/10.1016/j.schres.2017.10.035
   PubMed Web of Science ®Google Scholar
• Cuesta, M. J., Peralta, V., Zarzuela, A., Calvo, R., Garcı́a, M. a., & Serrano, F. n. (2002). Neurological soft-signs in psychosis: Threshold criteria for discriminating normal controls and for predicting cognitive impairment. Schizophrenia Research, 58(2–3), 263–271. https://doi.org/10.1016/S0920-9964(01)00390-5
   PubMed Web of Science ®Google Scholar
• Dean, D. J., Scott, J., & Park, S. (2021). Interpersonal coordination in schizophrenia: A scoping review of the literature. Schizophrenia Bulletin, 47(6), 1544–1556. https://doi.org/10.1093/schbul/sbab072
   PubMed Web of Science ®Google Scholar
• Devabhaktuni, S., Saldanha, D., Chaudhury, S., & Sahu, S. (2019). Neurological soft signs in positive and negative subtypes of schizophrenia. Medical Journal of Dr. DY Patil Vidyapeeth, 12(3), 227. https://doi.org/10.4103/mjdrdypu.mjdrdypu_26_18
   Google Scholar
• Dib, J. E., Adams, C. E., Kazour, F., Tahan, F., Haddad, G., Haddad, C., & Hallit, S. (2018). Managing acutely aggressive or agitated people in a psychiatric setting: A survey in Lebanon. Medical Journal of the Islamic Republic of Iran, 32, 60.
   PubMedGoogle Scholar
• Dickinson, D., Ramsey, M. E., & Gold, J. M. (2007). Overlooking the obvious: A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry, 64(5), 532–542. https://doi.org/10.1001/archpsyc.64.5.532
   PubMed Web of Science ®Google Scholar
• Emsley, R., Chiliza, B., Asmal, L., Kilian, S., Olivier, M. R., Phahladira, L., Ojagbemi, A., Scheffler, F., Carr, J., & Kidd, M. (2017). Neurological soft signs in first-episode schizophrenia: State-and trait-related relationships to psychopathology, cognition and antipsychotic medication effects. Schizophrenia Research, 188, 144–150. https://doi.org/10.1016/j.schres.2017.01.034
   PubMed Web of Science ®Google Scholar
• Feng, Y., Wang, Z., Lin, G., Qian, H., Gao, Z., Wang, X., Li, M., Hu, X., & Li, Y. (2020). Neurological soft signs and neurocognitive deficits in remitted patients with schizophrenia, their first-degree unaffected relatives, and healthy controls. European Archives of Psychiatry and Clinical Neuroscience, 270(3), 383–391. https://doi.org/10.1007/s00406-019-01024-x
   PubMed Web of Science ®Google Scholar
• Fett, A.-K. J., Viechtbauer, W., Penn, D. L., van Os, J., & Krabbendam, L. (2011). The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neuroscience & Biobehavioral Reviews, 35(3), 573–588. https://doi.org/10.1016/j.neubiorev.2010.07.001
   PubMed Web of Science ®Google Scholar
• Fong, T. C., Ho, R. T., Wan, A. H., & Au-Yeung, F. S. (2017). Psychiatric symptoms mediate the effects of neurological soft signs on functional outcomes in patients with chronic schizophrenia: A longitudinal path-analytic study. Psychiatry Research, 249, 152–158. https://doi.org/10.1016/j.psychres.2017.01.023
   PubMed Web of Science ®Google Scholar
• Forbes, N., Carrick, L., McIntosh, A., & Lawrie, S. (2009). Working memory in schizophrenia: A meta-analysis. Psychological Medicine, 39(6), 889–905. https://doi.org/10.1017/S0033291708004558
   PubMed Web of Science ®Google Scholar
• Fountoulakis, K. N., Panagiotidis, P., Kimiskidis, V., & Nimatoudis, I. (2019). 12-Month stability of neurological soft signs in stabilized patients with schizophrenia. Nordic Journal of Psychiatry, 73(7), 451–461. https://doi.org/10.1080/08039488.2019.1649724
   PubMed Web of Science ®Google Scholar
• Fritze, S., Sambataro, F., Kubera, K. M., Bertolino, A. L., Topor, C. E., Wolf, R. C., & Hirjak, D. (2020). Neurological soft signs in schizophrenia spectrum disorders are not confounded by current antipsychotic dosage. European Neuropsychopharmacology, 31, 47–57. https://doi.org/10.1016/j.euroneuro.2019.11.001
   PubMed Web of Science ®Google Scholar
• Godbout, L., Limoges, F., Allard, I., Braun, C. M., & Stip, E. (2007). Neuropsychological and activity of daily living script performance in patients with positive or negative schizophrenia. Comprehensive Psychiatry, 48(3), 293–302. https://doi.org/10.1016/j.comppsych.2007.01.003
   PubMed Web of Science ®Google Scholar
• Green, M. F., & Harvey, P. D. (2014). Cognition in schizophrenia: Past, present, and future. Schizophrenia Research: Cognition, 1(1), e1–e9. https://doi.org/10.1016/j.scog.2014.02.001
   PubMedGoogle Scholar
• Habtewold, T. D., Rodijk, L. H., Liemburg, E. J., Sidorenkov, G., Boezen, H. M., Bruggeman, R., & Alizadeh, B. Z. (2020). A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits. Translational Psychiatry, 10(1), 1–24. https://doi.org/10.1038/s41398-020-00919-x
   PubMed Web of Science ®Google Scholar
• Haddad, C., Salameh, P., Hallit, S., Obeid, S., Haddad, G., Clément, J., & Calvet, B. (2021). Cross-cultural adaptation and validation of the Arabic version of the BACS scale (the brief assessment of cognition in schizophrenia) among chronic schizophrenic inpatients. BMC Psychiatry, 21(1), 1–12. https://doi.org/10.1186/s12888-020-02964-8
   PubMed Web of Science ®Google Scholar
• Haddad, C., Salameh, P., Hallit, S., Sacre, H., Clément, J., & Calvet, B. (2021). Self-assessment of social cognition in a sample of Lebanese in-patients with schizophrenia. Schizophrenia Research: Cognition, 26, 100207. https://doi.org/10.1016/j.scog.2021.100207
   PubMedGoogle Scholar
• Hallit, S., Obeid, S., Haddad, C., Kazour, F., & Kazour, G. (2017). Validation of the Arabic version of the PANSS scale among Lebanese schizophrenic patients. Journal of Psychopathology, 23(2), 60–66.
   Google Scholar
• Hamdioui, S., & Lotfi, S. (2016). Psychomotor disorders in schizophrenia: A systematic review. Middle-East Journal of Scientific Research, 24(4), 1078–1085.
   Google Scholar
• Hani, Y., Ghuloum, S., Mahfoud, Z., Opler, M., Khan, A., Yehya, A., Abdulhakam, A., Hammoudeh, S., Al-Mujalli, A., & Elsherbiny, R. (2016). Validation of the Arabic version of Calgary depression scale for schizophrenia. PloS One, 11(9), e0162304. https://doi.org/10.1371/journal.pone.0162304
   PubMed Web of Science ®Google Scholar
• Herold, C. J., Duval, C. Z., Lässer, M. M., & Schröder, J. (2019). Neurological soft signs (NSS) and cognitive impairment in chronic schizophrenia. Schizophrenia Research: Cognition, 16, 17–24. https://doi.org/10.1016/j.scog.2018.12.002
   PubMedGoogle Scholar
• Herold, C. J., Duval, C. Z., & Schröder, J. (2021). Neurological soft signs and cognition in the late course of chronic schizophrenia: A longitudinal study. European Archives of Psychiatry and Clinical Neuroscience, 271(8), 1465–1473. https://doi.org/10.1007/s00406-020-01138-7
   PubMed Web of Science ®Google Scholar
• Herold, C. J., Lässer, M. M., Seidl, U. W., Hirjak, D., Thomann, P. A., & Schröder, J. (2018). Neurological soft signs and psychopathology in chronic schizophrenia: A cross-sectional study in three age groups. Frontiers in Psychiatry, 9, 98. https://doi.org/10.3389/fpsyt.2018.00098
   PubMed Web of Science ®Google Scholar
• Iasevoli, F., D'Ambrosio, L., Francesco, D. N., Razzino, E., Buonaguro, E. F., Giordano, S., Patterson, T. L., & de Bartolomeis, A. (2018). Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients. Schizophrenia Research, 202, 217–225. https://doi.org/10.1016/j.schres.2018.06.030
   PubMed Web of Science ®Google Scholar
• Jones, M. T., & Harvey, P. D. (2020). Major neuropsychological impairments in schizophrenia patients: Clinical implications. Current Psychiatry Reports, 22(11), 1–7. https://doi.org/10.1007/s11920-020-01181-0
   PubMed Web of Science ®Google Scholar
• Katz, S., Ford, A. B., Moskowitz, R. W., Jackson, B. A., & Jaffe, M. W. (1963). Studies of illness in the aged: The index of ADL: A standardized measure of biological and psychosocial function. JAMA, 185(12), 914–919. https://doi.org/10.1001/jama.1963.03060120024016
   PubMed Web of Science ®Google Scholar
• Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. https://doi.org/10.1093/schbul/13.2.261
   PubMed Web of Science ®Google Scholar
• Keefe, R. S., Goldberg, T. E., Harvey, P. D., Gold, J. M., Poe, M. P., & Coughenour, L. (2004). The brief assessment of cognition in schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research, 68(2–3), 283–297. https://doi.org/10.1016/j.schres.2003.09.011
   PubMed Web of Science ®Google Scholar
• Keefe, R. S., Harvey, P. D., Goldberg, T. E., Gold, J. M., Walker, T. M., Kennel, C., & Hawkins, K. (2008). Norms and standardization of the brief assessment of cognition in schizophrenia (BACS). Schizophrenia Research, 102(1–3), 108–115. https://doi.org/10.1016/j.schres.2008.03.024
   PubMed Web of Science ®Google Scholar
• Keefe, R. S., Poe, M., Walker, T. M., & Harvey, P. D. (2006). The relationship of the brief assessment of cognition in schizophrenia (BACS) to functional capacity and real-world functional outcome. Journal of Clinical and Experimental Neuropsychology, 28(2), 260–269. https://doi.org/10.1080/13803390500360539
   PubMed Web of Science ®Google Scholar
• Kim, S.-J., Jung, D., Shim, J.-C., Moon, J.-J., Jeon, D.-W., Kim, Y.-N., Seo, Y.-S., Jung, S.-S., Seo, B.-J., & Kim, J.-E. (2019). The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia. Asian Journal of Psychiatry, 46, 111–117. https://doi.org/10.1016/j.ajp.2019.10.013
   PubMed Web of Science ®Google Scholar
• Kochunov, P., Coyle, T. R., Rowland, L. M., Jahanshad, N., Thompson, P. M., Kelly, S., Du, X., Sampath, H., Bruce, H., Chiappelli, J., Ryan, M., Fisseha, F., Savransky, A., Adhikari, B., Chen, S., Paciga, S. A., Whelan, C. D., Xie, Z., Hyde, C. L., … Hong, L. E. (2017). Association of white matter with core cognitive deficits in patients with schizophrenia. JAMA Psychiatry, 74(9), 958–966. https://doi.org/10.1001/jamapsychiatry.2017.2228
   PubMed Web of Science ®Google Scholar
• Kong, L., Bachmann, S., Thomann, P. A., Essig, M., & Schröder, J. (2012). Neurological soft signs and gray matter changes: A longitudinal analysis in first-episode schizophrenia. Schizophrenia Research, 134(1), 27–32. https://doi.org/10.1016/j.schres.2011.09.015
   PubMed Web of Science ®Google Scholar
• Li, Z., Huang, J., Hung, K. S., Deng, Y., Wang, Y., Wang, Y., Lui, S. S., Mak, H. K., Sham, P. C., Cheung, E. F., Öngür, D., Dazzan, P., & Chan, R. C. K. (2021). Cerebellar hypoactivation is associated with impaired sensory integration in schizophrenia. Journal of Abnormal Psychology, 130(1), 102–111. https://doi.org/10.1037/abn0000636
   PubMed Web of Science ®Google Scholar
• Lui, S. S., Yip, S. S., Wang, Y., Hung, K. S., Ho, K. K., Tsang, K. C., Yeung, H. K., Cheung, E. F., & Chan, R. C. (2021). Different trajectories of neurological soft signs progression between treatment-responsive and treatment-resistant schizophrenia patients. Journal of Psychiatric Research, 138, 607–614. https://doi.org/10.1016/j.jpsychires.2021.05.018
   PubMed Web of Science ®Google Scholar
• Mohamed, S., Rosenheck, R., Swartz, M., Stroup, S., Lieberman, J. A., & Keefe, R. S. (2008). Relationship of cognition and psychopathology to functional impairment in schizophrenia. American Journal of Psychiatry, 165(8), 978–987. https://doi.org/10.1176/appi.ajp.2008.07111713
   PubMed Web of Science ®Google Scholar
• Monteiro, L. C., Silva, V. A., & Louzã, M. R. (2008). Insight, cognitive dysfunction and symptomatology in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 258(7), 402–405. https://doi.org/10.1007/s00406-008-0809-8
   PubMed Web of Science ®Google Scholar
• Morrens, M., Hulstijn, W., & Sabbe, B. (2007). Psychomotor slowing in schizophrenia. Schizophrenia Bulletin, 33(4), 1038–1053. https://doi.org/10.1093/schbul/sbl051
   PubMed Web of Science ®Google Scholar
• Nasser, R., & Doumit, J. (2009). Validity and reliability of the Arabic version of activities of daily living (ADL). BMC Geriatrics, 9(1), 1–7. https://doi.org/10.1186/1471-2318-9-11
   PubMedGoogle Scholar
• Papiol, S., Fatjó-Vilas, M., & Schulze, T. G. (2016). Neurological soft signs in patients with schizophrenia: Current knowledge and future perspectives in the post-genomics era. Translational Developmental Psychiatry, 4(1), 30071. https://doi.org/10.3402/tdp.v4.30071
   Google Scholar
• Peralta, V., Campos, M. S., De Jalón, E. G., & Cuesta, M. J. (2010). Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders. Movement Disorders, 25(8), 1068–1076. https://doi.org/10.1002/mds.23050
   PubMed Web of Science ®Google Scholar
• Pieters, L. E., Nadesalingam, N., Walther, S., & van Harten, P. N. (2022). A systematic review of the prognostic value of motor abnormalities on clinical outcome in psychosis. Neuroscience & Biobehavioral Reviews, 132, 691–705. https://doi.org/10.1016/j.neubiorev.2021.11.027
   PubMed Web of Science ®Google Scholar
• Rathod, B., Kaur, A., Basavanagowda, D. M., Mohan, D., Mishra, N., Fuad, S., Nosher, S., Alrashid, Z. A., & Heindl, S. E. (2020). Neurological soft signs and brain abnormalities in schizophrenia: A literature review. Cureus, 12(10), e11050. https://doi.org/10.7759/cureus.11050
   PubMed Web of Science ®Google Scholar
• Reichenberg, A. A. (2022). The assessment of neuropsychological functioning in schizophrenia. Dialogues in Clinical Neuroscience, 12(3), 383–392. https://doi.org/10.31887/DCNS.2010.12.3/areichenberg
   Google Scholar
• Rempfer, M. V., Hamera, E. K., Brown, C. E., & Cromwell, R. L. (2003). The relations between cognition and the independent living skill of shopping in people with schizophrenia. Psychiatry Research, 117(2), 103–112. https://doi.org/10.1016/S0165-1781(02)00318-9
   PubMed Web of Science ®Google Scholar
• Semkovska, M., Bédard, M.-A., Godbout, L., Limoge, F., & Stip, E. (2004). Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophrenia Research, 69(2–3), 289–300. https://doi.org/10.1016/j.schres.2003.07.005
   PubMed Web of Science ®Google Scholar
• Sum, M. Y., Tay, K. H., Sengupta, S., & Sim, K. (2018). Neurocognitive functioning and quality of life in patients with and without deficit syndrome of schizophrenia. Psychiatry Research, 263, 54–60. https://doi.org/10.1016/j.psychres.2018.02.025
   PubMed Web of Science ®Google Scholar
• Tripathi, R., Soni, A., Tyagi, A., Mehta, S., & Gupta, S. (2015). Comparative study of neurological soft signs in patients with schizophrenia or obsessive-compulsive disorder, and healthy controls. East Asian Archives of Psychiatry, 25(2), 64–72.
   PubMedGoogle Scholar
• Varlet, M., Marin, L., Raffard, S., Schmidt, R. C., Capdevielle, D., Boulenger, J.-P., Del-Monte, J., & Bardy, B. G. (2012). Impairments of social motor coordination in schizophrenia. PloS One, 7(1), e29772. https://doi.org/10.1371/journal.pone.0029772
   PubMed Web of Science ®Google Scholar
• Viher, P. V., Stegmayer, K., Bracht, T., Federspiel, A., Bohlhalter, S., Strik, W., Wiest, R., & Walther, S. (2022). Neurological soft signs are associated with altered white matter in patients with schizophrenia. Schizophrenia Bulletin, 48(1), 220–230. https://doi.org/10.1093/schbul/sbab089
   PubMed Web of Science ®Google Scholar